Services on Demand
Journal
Article
English (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Similars in
SciELO
Share
Permalink
Revista mexicana de neurociencia
On-line version ISSN 2604-6180Print version ISSN 1665-5044
Abstract
RESENDIZ-APARICIO, Juan C. et al. Attention deficit disorder, comorbidity, and treatment at the Hospital Psiquiátrico Infantil Dr. Juan N. Navarro, Mexico City. Rev. mex. neurocienc. [online]. 2020, vol.21, n.2, pp.41-48. Epub Mar 22, 2022. ISSN 2604-6180. https://doi.org/10.24875/rmn.19000133.
Background:
Attention deficit hyperactivity disorder (ADHD) is the main motive for consultation at the Hospital Psiquiátrico Infantil.
Materials and methods:
Prospective study analyzing patients with ADHD for 2 months.
Results:
Recruited 555 patients, average age 8.7 (± 1.66) years, 485 (87.4%) males and 70 (12.6%) females. The most frequent subtype was combined in 440 (79.3%). We observed high comorbidity (68.1%), with externalizing disorders 143 (25.8%) patients and internalizing disorders 136 (24.5%). Epilepsy was found in eight patients. The most commonly used medications were methylphenidate for 485 cases (87.4%), followed by risperidone 45 (8.1%), fluoxetine 32 (5.8%), and without drug treatment 31 (5.6%). Mood stabilizers in 102 patients (18.4%), 32% received more than one drug. The most frequent combinations were methylphenidate with valproate, methylphenidate with risperidone, and methylphenidate with fluoxetine.
Conclusions:
Males attend more frequently, and the most frequent subtype is combined. Comorbidity presented in almost 70%, most predominantly with the oppositional defiant disorder. Methylphenidate is the most commonly used drug in monotherapy or in combination.
Keywords : Attention deficit hyperactivity disorder; Comorbidity; Treatment; Methylphenidate.
